-+ 0.00%
-+ 0.00%
-+ 0.00%

Takeda Pharmaceutical Co Sees FY2026 GAAP EPS $0.66.

Benzinga·05/13/2026 11:00:10
Listen to the news

Takeda Pharmaceutical Co (NYSE:TAK) is looking for FY2026 GAAP EPS of $0.66.